Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: SOMAmer agent

Somalogic – proteomics tools

Posted on by

Somalogic is biotech company using its proprietary Slow Off-rate Modified Aptamer (“SOMAmer”) technology along with its unbiased biomarker discovery assay (SOMAscan) to develop new proteomics tools.

Somalogic – proteomics tools

somalogic

Continue reading →

Posted in Biotech Companies, Biotech Companies USA | Tagged Alister Reynolds, aptamer, Byron Hewett, Carrie Mulherin, Charles Lillis, Custom SOMApanels, Dan Muehl, Dennis Halladay, Diana Maul, drug discovery, Edward Brody, Evan King, Fintan Steele, high-affinity monoclonal antibody, Jennifer Hargrove, Jessica Tuchman Mathews, Larry Gold, mAb, mAbs, Mark Messenbaugh, monoclonal antibodies, monoclonal antibody, Nebojsa Janjic, Paul Menter, Preston Brown, proteomics, proteomics tools, Slow Off-rate Modified Aptamer, software, Somalogic, Somalogic - proteomics tools, SOMAmer, SOMAmer affinity, SOMAmer affinity reagent, SOMAmer affinity reagents, SOMAmer agent, SOMApanels, SOMAscan, SOMAscan assay, SomaSuite, Stephen Williams, Steven Morrissett, Terry Randall, unbiased biomarker discovery assay, Youichi Yabuuchi

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress